Maspin enhances cisplatin chemosensitivity in bladder cancer T24 and 5637 cells and correlates with prognosis of muscle-invasive bladder cancer patients receiving cisplatin based neoadjuvant chemotherapy
出版年份 2016 全文链接
标题
Maspin enhances cisplatin chemosensitivity in bladder cancer T24 and 5637 cells and correlates with prognosis of muscle-invasive bladder cancer patients receiving cisplatin based neoadjuvant chemotherapy
作者
关键词
Maspin, Muscle invasive bladder cancer, Cisplatin, Chemosensitivity
出版物
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 35, Issue 1, Pages -
出版商
Springer Nature
发表日期
2016-01-06
DOI
10.1186/s13046-015-0282-y
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- A panel of eight-miRNA signature as a potential biomarker for predicting survival in bladder cancer
- (2015) Hui Zhou et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- MK2206 potentiates cisplatin-induced cytotoxicity and apoptosis through an interaction of inactivated Akt signaling pathway
- (2015) Dingqi Sun et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- miR-101 Suppresses Vascular Endothelial Growth Factor C That Inhibits Migration and Invasion and Enhances Cisplatin Chemosensitivity of Bladder Cancer Cells
- (2015) Ye Lei et al. PLoS One
- Systems biology of cisplatin resistance: past, present and future
- (2014) L Galluzzi et al. Cell Death & Disease
- 5-Aza-2′-Deoxycytidine Enhances Maspin Expression and Inhibits Proliferation, Migration, and Invasion of the Bladder Cancer T24 Cell Line
- (2013) Huihui Zhang et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2013 Guidelines
- (2013) J. Alfred Witjes et al. EUROPEAN UROLOGY
- Maspin influences response to doxorubicin by changing the tumor microenvironment organization
- (2013) Tiziana Triulzi et al. INTERNATIONAL JOURNAL OF CANCER
- Maspin: molecular mechanisms and therapeutic implications
- (2012) Thomas M. Bodenstine et al. CANCER AND METASTASIS REVIEWS
- Increased expression of transcription factor TFAP2α correlates with chemosensitivity in advanced bladder cancer
- (2011) Iver Nordentoft et al. BMC CANCER
- Activation of the PI3K/Akt/mTOR pathway correlates with tumour progression and reduced survival in patients with urothelial carcinoma of the urinary bladder
- (2011) Chih-Hao Sun et al. HISTOPATHOLOGY
- Update on Chemotherapy in the Treatment of Urothelial Carcinoma
- (2011) Carrie Costantini et al. TheScientificWorldJOURNAL
- Phosphatidylinositol 3-Kinase Inhibitor LY294002 Suppresses Proliferation and Sensitizes Doxorubicin Chemotherapy in Bladder Cancer Cells
- (2011) Deyao Wu et al. UROLOGIA INTERNATIONALIS
- Long-term results of combined chemotherapy with gemcitabine and cisplatin for metastatic urothelial carcinomas
- (2010) Nozomu Tanji et al. International Journal of Clinical Oncology
- The Tumor Suppressor Maspin Mediates E2F1-Induced Sensitivity of Cancer Cells to Chemotherapy
- (2010) B. Ben Shachar et al. MOLECULAR CANCER RESEARCH
- Advanced bladder cancer: Status of first-line chemotherapy and the search for active agents in the second-line setting
- (2008) David J. Gallagher et al. CANCER
- Curcumin and cancer: An “old-age” disease with an “age-old” solution
- (2008) Preetha Anand et al. CANCER LETTERS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now